% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Adjei:289367,
      author       = {N. K. Adjei and F. Samkange-Zeeb and D. Boakye and M.
                      Saleem and L. Christianson and M. M. Kebede$^*$ and T. L.
                      Heise and T. Brand and O. B. Esan and D. C. Taylor-Robinson
                      and C. Agyemang and H. Zeeb},
      title        = {{E}thnic differences in metabolic syndrome in high-income
                      countries: {A} systematic review and meta-analysis.},
      journal      = {Reviews in endocrine $\&$ metabolic disorders},
      volume       = {25},
      number       = {4},
      issn         = {1389-9155},
      address      = {Dordrecht [u.a.]},
      publisher    = {Springer Science + Business Media B.V},
      reportid     = {DKFZ-2024-00757},
      pages        = {727-750},
      year         = {2024},
      note         = {2024 Aug;25(4):727-750},
      abstract     = {This review aimed to systematically quantify the
                      differences in Metabolic Syndrome (MetS) prevalence across
                      various ethnic groups in high-income countries by sex, and
                      to evaluate the overall prevalence trends from 1996 to 2022.
                      We conducted a systematic literature review using MEDLINE,
                      Web of Science Core Collection, CINAHL, and the Cochrane
                      Library, focusing on studies about MetS prevalence among
                      ethnic groups in high-income countries. We pooled 23 studies
                      that used NCEP-ATP III criteria and included 147,756 healthy
                      participants aged 18 and above. We calculated pooled
                      prevalence estimates and $95\%$ confidence intervals (CI)
                      using both fixed-effect and random-effect intercept logistic
                      regression models. Data were analysed for 3 periods:
                      1996-2005, 2006-2009, and 2010-2021. The pooled prevalence
                      of MetS in high-income countries, based on the NCEP-ATP III
                      criteria, was $27.4\%$ over the studied period, showing an
                      increase from $24.2\%$ in 1996-2005 to $31.9\%$ in
                      2010-2021, with men and women having similar rates. When
                      stratified by ethnicity and sex, ethnic minority women
                      experienced the highest prevalence at $31.7\%,$ while ethnic
                      majority women had the lowest at $22.7\%.$ Notably, MetS was
                      more prevalent in ethnic minority women than men. Among
                      ethnic minorities, women had a higher prevalence of MetS
                      than men, and the difference was highest in Asians (about 15
                      percentage points). Among women, the prevalence of MetS was
                      highest in Asians $(41.2\%)$ and lowest in Blacks/Africans
                      $(26.7\%).$ Among men, it was highest in indigenous minority
                      groups $(34.3\%)$ and lowest among in Blacks/Africans
                      $(19.8\%).$ MetS is increasing at an alarming rate in
                      high-income countries, particularly among ethnic minority
                      women. The burden of MetS could be effectively reduced by
                      tailoring interventions according to ethnic variations and
                      risk profiles.},
      subtyp        = {Review Article},
      keywords     = {Burden (Other) / Ethnicity (Other) / High-income Countries
                      (Other) / Meta-analysis (Other) / Metabolic syndrome (Other)
                      / Prevalence (Other)},
      cin          = {C020},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:38598068},
      doi          = {10.1007/s11154-024-09879-9},
      url          = {https://inrepo02.dkfz.de/record/289367},
}